PKM and cancer: The highly active tetramer PKM2 allows the increased glycolytic flux to meet the biosynthetic demand for the rapid proliferation of cancer cells, while dimeric PKM2 is prevalent in the nucleus functioning as a protein kinase when cells were in the proliferative stage [10, 11].